I am a two-time survior of the devasting bacterial infection known as C-Diff. Since I am an otherwise completely healthy female (was 35 and 44 when I contracted), it was unexpected that the disease would nearly kill me – twice. I have taken liquid vancomycin for nearly nine months now, but it has not cured me. I had the good fortune of learning from my infectious disease doctor and obtaining an opinion from an expert at Johns Hopkins Hospital about my case, and both concurred that I should consider opting for a fecal transplant as vancomycin hasn’t cured me. Although the procedure is usually done at the hospital and is 90-95% effective (so I am told), my husband and I are doing the home-style version. A fecal transplant is done by taking the stole of a healthy, close family member, mixing it with saline solution in a blender, putting it through a seive, and “inplanting” the donor’s good bacteria via an enema bottle into your intestines via your rectum. Although it was quite disgusting the first day, it gets easier. I noticed a dramatic improvement within 12 hours. Anyone having gone through a severe case of C-Diff knows that the fecal transplant procedure is not nearly as tramatic and painful as living with this infection. Quite frankly, the fecal transplant may save my life.
No, a flu shot cannot give you the flu. Flu vaccines that are administered with a needle are currently made in two ways: the vaccine is made either with a) flu vaccine viruses that have been ‘inactivated’ and are therefore not infectious, or b) with no flu vaccine viruses at all (which is the case for recombinant influenza vaccine). In randomized, blinded studies, where some people got flu shots and others got saltwater shots, the only differences in symptoms was increased soreness in the arm and redness at the injection site among people who got the flu shot. There were no differences in terms of body aches, fever, cough, runny nose or sore throat.
Fish oil fatty acids interact with the peroxisome proliferator-activated receptor (PPAR) system, which are a class of receptors (PPARα, PPARβ/δ, and PPARγ) that seem to respond to dietary lipids and similarly structured molecules. They are highly involved in the treatment of diabetes and metabolic syndrome (via the drug classes of fibrates and thiazolidinediones), with varying effects on fat mass (PPARα increases beta-oxidation of fatty acids,  while PPARγ promotes fat storage but improves insulin tolerance;  PPARδ appears to be similar to PPARα in this regard  ).